the use of antibodies directed against tumors has found increasing usefulness after the discovery by kohler and milstein of hybridoma technology , which made it possible to obtain monoclonal antibody ( moab ) that reacted specifically against a particular epitope on a particular antigen site .
C0003241
antibodies
C0003250
monoclonal antibody